161 related articles for article (PubMed ID: 8893069)
1. Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Oct; 53(19):2304-9. PubMed ID: 8893069
[TBL] [Abstract][Full Text] [Related]
2. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
[TBL] [Abstract][Full Text] [Related]
3. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
[TBL] [Abstract][Full Text] [Related]
4. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772
[TBL] [Abstract][Full Text] [Related]
5. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
[TBL] [Abstract][Full Text] [Related]
6. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Aug; 53(16):1944-9. PubMed ID: 8862208
[TBL] [Abstract][Full Text] [Related]
7. Stability of rifabutin in two extemporaneously compounded oral liquids.
Haslam JL; Egodage KL; Chen Y; Rajewski RA; Stella V
Am J Health Syst Pharm; 1999 Feb; 56(4):333-6. PubMed ID: 10690216
[TBL] [Abstract][Full Text] [Related]
8. Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids.
Fish DN; Vidaurri VA; Deeter RG
Am J Health Syst Pharm; 1999 Oct; 56(19):1957-60. PubMed ID: 10554914
[TBL] [Abstract][Full Text] [Related]
9. Stability of ganciclovir in extemporaneously compounded oral liquids.
Anaizi NH; Swenson CF; Dentinger PJ
Am J Health Syst Pharm; 1999 Sep; 56(17):1738-41. PubMed ID: 10512505
[TBL] [Abstract][Full Text] [Related]
10. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4.
Polonini H; da Silva SL; Brandão MAF; Bauters T; De Moerloose B; Ferreira AO
Int J Pharm Compd; 2018; 22(6):516-526. PubMed ID: 30384353
[TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
12. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
Nahata MC; Morosco RS; Hipple TF
Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
[TBL] [Abstract][Full Text] [Related]
13. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
[TBL] [Abstract][Full Text] [Related]
14. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
15. Stability of Adderall in extemporaneously compounded oral liquids.
Justice J; Kupiec TC; Matthews P; Cardona P
Am J Health Syst Pharm; 2001 Aug; 58(15):1418-21. PubMed ID: 11494787
[TBL] [Abstract][Full Text] [Related]
16. Stability of sotalol in two liquid formulations at two temperatures.
Nahata MC; Morosco RS
Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
[TBL] [Abstract][Full Text] [Related]
17. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
18. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
19. Stability of extemporaneously prepared rufinamide oral suspensions.
Hutchinson DJ; Liou Y; Best R; Zhao F
Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
[TBL] [Abstract][Full Text] [Related]
20. Stability of tiagabine in two oral liquid vehicles.
Nahata MC; Morosco RS
Am J Health Syst Pharm; 2003 Jan; 60(1):75-7. PubMed ID: 12533980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
